P
Porton Advanced / 博腾生物
CGT CDMO for plasmids, AAV/LVV, cell therapy and nucleic acids (Porton 300363)
About Porton Advanced / 博腾生物
Porton Advanced Solutions (苏州博腾生物制药 / Porton Biologics) is the cell and gene therapy CDMO arm of listed Porton Pharma Solutions (SZSE 300363). Founded in 2018 and based in Suzhou Industrial Park, it provides end-to-end plasmid, AAV, lentiviral vector, cell therapy, oncolytic virus, mRNA and related ATMP process development, analytics and GMP manufacturing for preclinical through commercial programs. Public disclosures cite ~200–500 employees, IND support for CAR-T/NK/MSC/mRNA/TCR-T and oncolytic programs, and dual China–US campuses including Ascendas Park and BioBay Mulberry Field Island in SIP plus Cranbury, New Jersey.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Suzhou Shi, China
- Employees
- 48
- Open positions
- 6
- Dealroom signal
- 45.0/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2022 | $80M | $320M | Porton Fine Chemicals · Gortune Investment · HM Capital · China Merchants Securities | ↗ |
| SERIES AOther financing | Apr 2021 | $55M | $220M | State Development & Investment Corporation (SDIC) · HM Capital | ↗ |
Growth signals
Latest recorded traffic for Porton Advanced / 博腾生物 is 3.2K monthly website visits, down 5.9% over the last three months. Porton Advanced / 博腾生物's team grew 2.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Porton Advanced / 博腾生物 in the Suzhou Shi ecosystem
The Porton Advanced / 博腾生物 office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
State Development & Investment Corporation (SDIC)
HM Capital
Porton Fine Chemicals- GIGortune Investment
- CSChina Merchants Securities
CS Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Porton Advanced / 博腾生物 on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Porton Advanced / 博腾生物’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









